The relationship between cognitive function and cortical thickness in first-episode drug-naive schizophrenia patients with agitation

首次发作且未接受药物治疗的精神分裂症伴躁动患者的认知功能与皮质厚度之间的关系

阅读:1

Abstract

OBJECTIVE: This study aims to explore the relationships between the agitation behavior, cognitive function and cortical thickness in first-episode drug-naïve schizophrenia (FESN). METHODS: A total of 55 male healthy controls (HC) and 79 male inpatients with FESN were enrolled in the present study. Whole brain cortical thickness was extracted from T1-weighted MRI using Freesurfer Version 7.4.1 software package. Cognitive function was evaluated using the MATRICS Consensus Cognitive Battery (MCCB). The Positive and Negative Syndrome Scale-Excited Component (PANSS-EC) is used to divide these inpatients into agitation group (FESN+A) and non-agitation group (FESN+NA). Correlation analysis was employed to investigate the potential associations between cortical thickness and cognitive function. RESULTS: The FESN+A group had higher Positive and Negative Syndrome Scale (PANSS) total score, positive symptom score, and general psychopathology score than the FESN+NA group. Both the FESN+A/NA groups showed significantly worse performance than the HC in symbol coding, working memory, attention/vigilance, reasoning and problem solving, and social cognition. The FESN+A group performed worse on working memory when comparing to FESN+NA group. Furthermore, the cortical thickness of the left paracalcarine gyrus was increased in the FESN+NA group, compared to HC. FESN+A group had thicker cortical thickness in the right posterior cingulate cortex (rPCC) compared with the FESN+NA group. The cortical thickness of rPCC was negatively correlated with score of working memory in the FESN+A group. CONCLUSION: The present study demonstrated that the abnormal cortical thickness of rPCC may be related to the agitation behavior and cognitive function in patients with FESN+A, suggesting a potential treatment target for agitation behavior and cognitive impairment in schizophrenia.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。